Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance, Inc. - Common Stock (NQ: WBA )

12.52 -0.41 (-3.17%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Walgreens Boots Alliance, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
Walgreens Posts Upbeat Earnings, Joins Wolfspeed, Ericsson And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Walgreens Boots Alliance Outlines Three-Cost Saving Strategy As Q4 Earnings Beat Street Estimates
Walgreens Boots Alliance reported Q4 FY2024 sales of $37.55B, a 6% increase year-over-year, with pharmacy sales up 9.6%. Adjusted EPS was $0.39, beating analyst expectations. Key growth seen in U.S.... 
Via Benzinga
Topics Earnings
Exposures Financial
Walgreens Stock Jumps As Ailing Drug Store Giant Plans To Cut 1,200 Locations
Walgreens topped Q4 EPS views and plans to cut 1,200 drug store locations. 
Via Investor's Business Daily
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
Wall Street mood has become circumspect as traders gear up to receive a slew of earnings reports this week amid the market’s record run. The Nasdaq Composite has been a laggard among the major averages... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Preview For Walgreens Boots Alliance
Via Benzinga
Navigating 5 Analyst Ratings For Walgreens Boots Alliance
Via Benzinga
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd 
Via News Direct
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally
The stock market has been on a two-year strong run and the extended rally has begun to stir valuation concerns. 
Via Benzinga
Walgreens Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Citigroup, Bank of America And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Major Indexes Finish Higher As Earnings Season Sets In
Upbeat post-earnings sentiment sent the Dow and S&P 500 to fresh record highs, with big banks among those making major moves, as well as a myriad of blue-chip leaders. 
Via Talk Markets
Topics Stocks
Exposures US Equities
The Bull's Biggest Hits And Misses
The bull market turned two years old over the weekend. Here are some of the S&P 500's biggest winners and losers over the last two years. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Large-Cap Stocks In Trouble - Sunday, Oct. 13
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns. 
Via Talk Markets
Walgreens: A New Risk Just Emerged for the Stock
Can this pharmacy retailer overcome this latest threat? 
Via The Motley Fool
Troubled Victoria’s Secret stock could surge by 72%
Victoria’s Secret (VSCO) stock has stabilized in the past few weeks as investors focus on the recent leadership transition and the ongoing turnaround. 
Via Talk Markets
Where Does Hims & Hers Stock Go From Here?
Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright? 
Via The Motley Fool
Exposures Product Safety
Palo Alto Networks To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026,... 
Via Benzinga
Walgreens Boots Alliance vs. Altria Group: What's the Better Dividend Stock to Own?
These stocks offer a lot of dividend income, but are they worth the risk? 
Via The Motley Fool
2 Ultra-High-Yield Dividend Stocks Are Near 52-Week Lows. Is It Time to Buy the Dips?
With yields of 8% or better at recent prices, these dividend payers are hard to ignore. 
Via The Motley Fool
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
Via Benzinga
Best Stock to Buy Right Now: Opendoor Technologies vs. Realty Income
Which of these real estate stocks is a better buy as interest rates decline? 
Via The Motley Fool
CVS Health Business Model Is Under Attack — By CVS Board
CVS stock is still underwater and CVS Health's board is out of patience, nearly seven years after its Aetna acquisition to build a new model delivering health care out of its stores. 
Via Investor's Business Daily
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
Via Benzinga
5 Things You Need to Know If You Buy Walgreens Today
The stock for this pharmacy chain has struggled mightily this year. 
Via The Motley Fool
Should You Buy Walgreens Boots Alliance for Its 11.1% Dividend Yield? 3 Things to Know First
This eye-popping dividend yield may give you more headaches than passive income. 
Via The Motley Fool
Why Are Dollar Tree And Dollar General Stocks Falling Apart?
Discount retailers like Dollar Tree (DLTR) and Dollar General (DG​​​​​​​) are some of the worst performers in the S&P 500 index this year. DLTR has slumped by 50% in 2024, bringing its market cap to... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules
Eli Lilly appeals a $183 million judgment in a Medicaid fraud case, arguing that it followed a reasonable interpretation of the law. The case has drawn attention from major business and pharmaceutical... 
Via Benzinga
Topics Fraud
Exposures Legal
3 Reasons Why Walgreens Boots Alliance Stock May Not Be Doomed
Walgreens stock has been a falling knife this year, but the company has levers it can pull on to strengthen its operations. 
Via The Motley Fool
Best And Worst Performers Since 8/5
The large-cap S&P 500 and Russell 1,000 are both now up more than 10% since the summer low made on August 5th. 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
54 55 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.